Owen Mumford and Noble International Announce Collaboration on Patient Training Solutions for Unisafe® Drug Delivery Devices

Under this agreement, Noble will create patient-centered training devices for Owen Mumford’s UniSafe^® safety syringe platform. Noble will also design and provide comprehensive training programs and materials to help educate and support patients as they use their injection devices. The goal is to improve adherence to therapy and build patient confidence.

Recent research indicates that a surprising one out of three patients doesn’t receive formal training when prescribed a self-injectable therapy by their healthcare provider. For those who do receive training, it lasts an average of just 16 minutes, which can discourage patients from asking questions or practicing. 1

“We recognize how important it is to deliver thorough training for drug delivery devices, especially for new patients or those experiencing dexterity issues. Patients will greatly benefit from learning to use our UniSafe^® 1mL spring-free design, which is already easy to use and includes safety features like a protected needle and integrated plunger,” said Michael Earl, Director of Owen Mumford Pharmaceutical Services. “We look forward to partnering with Noble. Their extensive experience in comprehensive training programs will help give UniSafe^® patients the confidence they need to use their medication correctly and stick to prescribed treatments, ultimately leading to better outcomes.”

“This partnership further demonstrates both organizations’ dedication to giving patients the tools and resources needed for better health results,” said Jeff Miller, Director of Business Development at Noble. “Noble’s deep understanding of the concerns and challenges self-injecting patients face, combined with Owen Mumford’s expertise in devices, helps patients start their therapies sooner and maintain them longer.”